AXP vs SCNI · P/E 20, rev $21.73B vs P/E 0.2, rev $1.3M
American Express Company (AXP) versus Scinai Immunotherapeutics Ltd (SCNI) — a side-by-side from cached financials, not a winner call.
American Express Company (AXP) is a credit services company listed on US. It is led by Stephen Joseph Squeri.
Scinai Immunotherapeutics Ltd (SCNI) is a biotechnology company listed on NASDAQ.
Latest reported AXP revenue for 2026-06-30 was $21.73B. Net income was $6.08B. AXP currently screens at market cap $215.94B and trailing P/E 19.8.
Latest reported SCNI revenue for 2025-12-31 was $1.3M. Net income was -$8.3M. Revenue was up 99.2% from 2024-12-31 to 2025-12-31. SCNI currently screens at market cap $1.8M and trailing P/E 0.2.
AXP currently screens at market cap $215.94B and trailing P/E 19.8. SCNI currently screens at market cap $1.8M and trailing P/E 0.2.
Not investment advice. Open the AXP and SCNI stock pages for the full models.
Not investment advice.